82 FR 28697 - Cancellation Notification of the Public Teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission)

EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy

Federal Register Volume 82, Issue 120 (June 23, 2017)

ONDCP is issuing this notice to advise the public that the Commission is cancelling the teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis that was previously scheduled for Monday, June 26th at 4 p.m. EST. Please check the Commission's Web site or future Federal Register notices for information about when this meeting will be rescheduled.

[Federal Register Volume 82, Number 120 (Friday, June 23, 2017)]
[Notices]
[Page 28697]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-13183]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Cancellation Notification of the Public Teleconference of the 
President's Commission on Combating Drug Addiction and the Opioid 
Crisis (Commission)

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of cancellation of teleconference.

-----------------------------------------------------------------------

SUMMARY: ONDCP is issuing this notice to advise the public that the 
Commission is cancelling the teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis that was 
previously scheduled for Monday, June 26th at 4 p.m. EST. Please check 
the Commission's Web site or future Federal Register notices for 
information about when this meeting will be rescheduled.

DATES: The cancellation is effective on June 20, 2017.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public wishing to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wishes to 
submit written comments for the Commission's consideration may contact 
Michael Passante, Designated Federal Officer (DFO) via email at 
[email protected] or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and;
    f. make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: June 20, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-13183 Filed 6-22-17; 8:45 am]
 BILLING CODE 3280-F5-P